Skip to main content

previous disabled Page of 11
and
  1. Article

    Open Access

    A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)

    Therapeutic options for early-stage hepatocellular carcinoma (HCC) in individual patients can be limited by tumor and location, liver dysfunction and comorbidities. Many patients with early-stage HCC do not re...

    Alan Wigg, Jonathan Tibballs, Richard Woodman, Katherine Stuart, Hien Le in BMC Cancer (2024)

  2. Article

    Open Access

    Clinical applications of telemedicine services using a regional telemedicine platform for cancer treatment: a cross-sectional study

    Telemedicine is beneficial for improving treatment efficiency and reducing medical expenses of cancer patients. This study focuses on cancer patients participating in teleconsultations through a regional telem...

    Fangfang Cui, Xu Zhang, **anying He, Dongqing Liu, **ming Shi, Ming Ye in BMC Cancer (2024)

  3. Article

    Open Access

    Isorhapontigenin inhibition of basal muscle-invasive bladder cancer attributed to its downregulation of SNHG1 and DNMT3b

    Bladder cancer (BC) is among the most prevalent malignant urothelial tumors globally, yet the prognosis for patients with muscle-invasive bladder cancer (MIBC) remains dismal, with a very poor 5-year survival ...

    Hao Meng, Rui Yang, Qianqian Lin, Wenqi Du, Zheng Chu, Yaxin Cao in BMC Cancer (2024)

  4. Article

    Open Access

    Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study

    Resistance to immune checkpoint inhibitors (ICIs) represents a major unmet medical need in non-small cell lung cancer (NSCLC) patients. Vascular endothelial growth factor (VEGF) inhibition may reverse a suppre...

    Bo Zhang, Hongyu Liu, Chunlei Shi, Zhiqiang Gao, Runbo Zhong, Aiqin Gu in BMC Cancer (2024)

  5. No Access

    Article

    Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling

    There is a need for diagnostic tests for screening, triaging and staging of epithelial ovarian cancer (EOC). Glycoproteomics of blood samples has shown promise for biomarker discovery.

    Chirag Dhar, Prasanna Ramachandran, Gege Xu, Chad Pickering in British Journal of Cancer (2024)

  6. Article

    Open Access

    Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration

    GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.

    Chen-Yang Tao, **ao-Ling Wu, Shu-Shu Song, Zheng Tang, Yu-Fu Zhou in Cellular Oncology (2024)

  7. Article

    Open Access

    STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma

    Esophageal squamous cell carcinoma (ESCC) is an aggressive disease with a poor prognosis, caused by the inactivation of critical cell growth regulators that lead to uncontrolled proliferation and increased mal...

    Ziying Zhao, Yuan Chu, Anqi Feng, Shihan Zhang, Hao Wu, Zhaoxing Li in Cellular Oncology (2024)

  8. Article

    Open Access

    Intratumoral presence of the genotoxic gut bacteria pks+ E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer

    This study aimed to investigate clinicopathological and molecular tumour features associated with intratumoral pks+ Escherichia coli (pks+E.coli+), pks+E.coli- (non-E.coli bacteria harbouring the pks island), Ent...

    Jihoon E. Joo, Yen Lin Chu, Peter Georgeson, Romy Walker in British Journal of Cancer (2024)

  9. No Access

    Article

    Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response

    Epithelial-mesenchymal transition (EMT) is a complicated molecular process that governs cellular shape and function changes throughout tissue development and embryogenesis. In addition, EMT contributes to the ...

    Nasim Ebrahimi, Mahdokht Sadat Manavi in Cancer and Metastasis Reviews (2024)

  10. No Access

    Article

    A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer

    Cadonilimab is a bispecific antibody that simultaneously targets programmed cell death receptor-1 and cytotoxic T lymphocyte-associated antigen-4. This study aimed to assess the safety and efficacy of cadonili...

    Bolin Chen, Wenxiu Yao, **ngya Li, Gen Lin, Qian Chu in British Journal of Cancer (2024)

  11. No Access

    Article

    Multimodality imaging reveals angiogenic evolution in vivo during calvarial bone defect healing

    The healing of calvarial bone defects is a pressing clinical problem that involves the dynamic interplay between angiogenesis and osteogenesis within the osteogenic niche. Although structural and functional va...

    Yunke Ren, **nying Chu, Janaka Senarathna, Akanksha Bhargava in Angiogenesis (2024)

  12. Article

    Open Access

    FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer

    Ovarian cancer is one of the most common gynecological malignancies due to the lack of early symptoms, early diagnosis and limited screening. Therefore, it is necessary to understand the molecular mechanism un...

    Gendi Song, Zhengwei Sun, Man Chu, Zihan Zhang, Jiajia Chen, Zhiwei Wang in BMC Cancer (2024)

  13. Article

    Open Access

    Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study

    To investigate the predictive value of baseline C-reactive protein (CRP) levels on the efficacy of chemotherapy plus immune checkpoint inhibitors (ICI) in patients with advanced lung squamous cell carcinoma (L...

    **nlong Zheng, Longfeng Zhang, Lin Wu, Jun Zhao, Jianguo Sun, Yong Fang in BMC Cancer (2023)

  14. Article

    Open Access

    Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database

    Multiple myeloma (MM) remains incurable despite the availability of novel agents. This multi-center retrospective cohort study used the Canadian Myeloma Research Group Database to describe real-world outcomes ...

    A. Visram, A. De La Torre, D. White, J. Su, E. Masih-Khan, M. Chu in Blood Cancer Journal (2023)

  15. Article

    Open Access

    Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database

    Autologous stem cell transplant (ASCT) remains an important option for eligible multiple myeloma (MM) patients as part of initial therapy. Using the Canadian Myeloma Research Group (CMRG) national database, we...

    Julie Côté, Richard LeBlanc, Hira Mian, Michael P. Chu in Blood Cancer Journal (2023)

  16. No Access

    Article

    The composition and roles of gastric stem cells in epithelial homeostasis, regeneration, and tumorigenesis

    The epithelial lining of the stomach undergoes rapid turnover to preserve its structural and functional integrity, a process driven by long-lived stem cells residing in the antral and corpus glands. Several su...

    Meng Liu, Qin Liu, Qiang Zou, **yang Li, Zhaole Chu, Junyu **ang in Cellular Oncology (2023)

  17. No Access

    Article

    Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells

    Cetuximab, an epidermal growth factor receptor (EGFR) inhibitor, is extensively used for clinical therapy in KRAS wild-type colorectal cancer (CRC) patients. However, some patients still cannot get benefit fro...

    Yongming Lv, Wenhong Wang, Yanfei Liu, Ben Yi in Clinical & Experimental Metastasis (2023)

  18. Article

    Open Access

    Role of SH3GLB1 in the regulation of CD133 expression in GBM cells

    Glioblastoma (GBM), a malignant brain tumor, has poor survival outcomes due to recurrence or drug resistance. We found that SH3GLB1 is a crucial factor for cells to evade temozolomide (TMZ) cytotoxicity throug...

    Chia-Hung Chien, Chien-Cheng Lai, Jian-Ying Chuang, Jui-Mei Chu in BMC Cancer (2023)

  19. Article

    Open Access

    EBV antibody and gastric cancer risk: a population-based nested case-control study in southern China

    We aim to clarify the controversial associations between EBV-related antibodies and gastric cancer risk.

    Yun Du, **a Yu, Ellen T. Chang, Li Yin, Shifeng Lian, Biaohua Wu, Fugui Li in BMC Cancer (2023)

  20. Article

    Open Access

    A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models

    Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer and is notorious for its resistance to both chemotherapy and small-molecule inhibitor targeted therapies. Subcellular targeted c...

    Stefan Mrdenovic, Yan** Wang, Lijuan Yin, Gina Chia-Yi Chu, Yan Ou in BMC Cancer (2023)

previous disabled Page of 11